Executive Director, Global Value and Access

Who We Are

BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.

Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.

Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.

About Commercial

Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin’s commercial presence in the United States and Europe, Latin America, the Middle East and Asia-Pacific.

Position Overview: The Executive Director, Global Value and Access will report to the SVP Global Value Access and Strategic Pricing (GVASP) and will be part of the GVASP Leadership Team. This role will lead a team of V&A experts responsible for developing and executing differentiated global market access and pricing strategies that demonstrate the value of our innovative therapies and support optimal patient access while also directly shaping those strategies.   The ideal candidate will have a demonstrable track record of developing and/or overseeing the development of innovative access and pricing strategies, key value materials and tools in multiple markets. A solid analytical background, strategic thinking, a deep understanding of U.S. and international healthcare systems (including but not limited to Brazil, Germany, Italy and Japan), payer requirements, preferences, and market dynamics is required. Rare diseases experience is preferred.   Responsibilities: 

• Accountability for the development of Global Integrated Access and Pricing strategies to maximize the value of our current and future assets by a team of direct reports (Global and Local) V&A Leads and other Global, Regional and Local partners. 

• Accountability for the creation and governance of V&A key deliverables for the portfolio of products and pipeline assets in alignment with Business Units and International partners. 

• Leading a high-performing direct (Global and Local) and matrixed team of Value, Access and Pricing experts.  

• Ensuring strategic market access input is provided to guide global clinical development programs, so these are optimized to meet the needs of global payers. Experience collecting and incorporating payers’ and other stakeholder’ perspectives through early engagement with ad boards, primary research, and analysis of select secondary research is required. 

• Overseeing and actively participating in the generation of the global V&A strategy, integrated evidence plans input, value propositions, and stakeholder engagement planning. 

• Developing and maintaining strong business relationships with key functions responsible for value proposition enablement, focusing on Clinical, Commercial, Regulatory, Medical Affairs and Government Affairs and HEOR. 

• Overseeing the identification and communication of evidence requirements for successful access of our products and supporting the development of evidence generation plans in collaboration with HEOR and Medical Affairs. Ability to communicate and influence effectively is a must. 

• Driving the design of V&A services and key deliverables for optimal alignment, support, and efficiency. And co-leading international best practice sharing with the V&A Head of International markets and Head of U.S V&A. 

• Monitoring, analyzing, and communicating global market access and pricing trends, competitor activities, and policy changes to anticipate future market dynamics to build new capabilities and adjust strategies accordingly. 

• Supporting the execution of broader market access goals, including pricing targets, access timelines, and overall launch success. 

• Leading the development of pricing estimates, value propositions and access plans for pipeline and potential assets acquisitions. 

• Providing strategic leadership as an active member of GV&A's leadership team (LT) and shaping the team's strategy, priorities, and activities i